| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 3e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |